Skip to main content

Eversept Partners, LP

Source: SEC Form 13F · as of Mar 2026

Eversept Partners, LP holds 41 biotech & pharma companies tracked by BioSniper, totaling $596.4M in value as of Mar 2026 (SEC Form 13F).

Companies held

41

Total value held

$596.4M

BioSniper AIPage evidence connected

Prepared research question

What matters most for Abivax SA (ABVX)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
ABVXAbivax SA934,423$104.0M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)1,785,175$98.5M
CLDXCelldex Therapeutics, Inc.1,788,016$56.7M
PCVXVaxcyte, Inc.924,193$53.7M
IONSIONIS PHARMACEUTICALS INC632,100$47.5M
GERNGERON CORP18,834,883$28.1M
LQDALiquidia Corp677,392$25.6M
TVTXTravere Therapeutics, Inc.542,610$16.1M
CTMXCytomX Therapeutics, Inc.3,188,514$15.0M
VRDNViridian Therapeutics, Inc.\DE713,269$14.0M
ARQTArcutis Biotherapeutics, Inc.576,580$13.6M
ARDXARDELYX, INC.2,229,446$13.4M
BMRNBIOMARIN PHARMACEUTICAL INC207,768$11.7M
PHVSPharvaris N.V.406,960$11.5M
NAMSNEWAMSTERDAM PHARMA CO N.V.285,764$9.1M
MRNAModerna, Inc.159,708$8.1M
VKTXViking Therapeutics, Inc.239,110$7.8M
AGIOAGIOS PHARMACEUTICALS, INC.200,000$6.8M
GPCRStructure Therapeutics Inc.138,036$6.7M
ESPREsperion Therapeutics, Inc.1,735,963$4.8M
DAWNDay One Biopharmaceuticals, Inc.183,902$3.9M
CMPSCOMPASS Pathways plc677,924$3.7M
GRCEGrace Therapeutics, Inc.756,600$3.5M
DFTXDefinium Therapeutics Inc.160,723$3.0M
IVVDInvivyd, Inc.2,276,349$3.0M
ALECAlector, Inc.1,351,106$2.9M
LBRXLB PHARMACEUTICALS INC100,198$2.5M
LPCNLipocine Inc.294,989$2.4M
SVRASavara Inc384,264$2.1M
RLMDRELMADA THERAPEUTICS, INC.277,899$1.9M
STROSUTRO BIOPHARMA, INC.73,161$1.8M
INOINOVIO PHARMACEUTICALS, INC.1,035,360$1.8M
SRZNSurrozen Inc.58,624$1.7M
IFRXInflaRx N.V.1,758,573$1.6M
ANABANAPTYSBIO, INC27,089$1.5M
IMCRImmunocore Holdings plc39,238$1.2M
ASMBASSEMBLY BIOSCIENCES, INC.40,889$1.1M
PLRXPLIANT THERAPEUTICS, INC.891,425$1.1M
SPRYARS Pharmaceuticals, Inc.136,235$1.1M
WHWKWhitehawk Therapeutics, Inc.306,800$1.1M
BCYCBICYCLE THERAPEUTICS PLC190,715$885K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.